SDJ

Adjunctive Cardiac Amyloidosis Status Indicator

Product code
SDJ
Device name
Adjunctive Cardiac Amyloidosis Status Indicator
Device class
Class 2
21 CFR
21 CFR 870.2200
Medical specialty
Cardiovascular
Marketing pathway
510(K)
510(k) clearances (last 3 years)
3
Summaries archived here
3 (direct download)
510(k) clearances (all years, FDA)
3 (all years; only the last 3 years are listed here)

FDA classification definition

The adjunctive cardiac amyloidosis status indicator is a prescription device based on sensor technology or image data to provide information to an interpreting clinician in detecting cardiac amyloidosis. This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (3)

Last three years. Most recent: 2025-06-20.

NumberDecision dateApplicantDevice nameSummary
K2501512025-06-20Eko.Ai Pte Ltd. D/B/A Us2.AiUs2.caPDF
K2438662025-05-21InVision Medical Technology Corporatio…InVision Precision Cardiac AmyloidPDF
K2408602024-11-15Ultromics LimitedEchoGo Amyloidosis (1.0)PDF

3 summaries are archived here for direct download.

Official FDA classification page: SDJ
Classification and pathway per current FDA publications. Data from openFDA (CC0).